media won�t investigate medically-caused death numbers . . print .

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the ., and bones, and it�s not clear how the drugs will affect them after long-term use.